Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025)

Palomino Laboratories recorded quarterly Total Current Liabilities of $336458.0 in Q4 2025, down 66.32% quarter-over-quarter from $999013.0 in Q3 2025, and up 5131.81% year-over-year from $6431.0 in Q4 2024.

Palomino Laboratories' Total Current Liabilities history runs 4 years deep, the most recent figure standing at $336458.0 for Q4 2025.

  • In Q4 2025, Total Current Liabilities rose 5131.81% year-over-year to $336458.0; the TTM figure through Dec 2025 stood at $336458.0 (up 5131.81% YoY), while the FY2025 annual figure was $336458.0, up 5131.81% from the prior year.
  • Total Current Liabilities came in at $336458.0 for Q4 2025 at Palomino Laboratories, down from $999013.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $6431.0 in Q4 2024.
  • A 4-year average of $258284.6 and a median of $194658.0 in 2024 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities slumped 94.24% in 2024 and jumped 5131.81% in 2025, its largest moves.
  • Palomino Laboratories' Total Current Liabilities stood at $27804.0 in 2022, then soared by 301.46% to $111621.0 in 2023, then plunged by 94.24% to $6431.0 in 2024, then surged by 5131.81% to $336458.0 in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $336458.0, $999013.0, and $364431.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 336,458.00
Sep 30, 2025 999,013.00
Jun 30, 2025 364,431.00
Mar 31, 2025 336,989.00
Dec 31, 2024 6,431.00
Sep 30, 2024 221,754.00
Jun 30, 2024 194,658.00
Mar 31, 2024 162,925.00
Dec 31, 2023 111,621.00
Sep 30, 2023 79,047.00
Dec 31, 2022 27,804.00